Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Neuroblastoma (NB) is the most common cancer in childhood and infancy. Neuroblastoma is a cancer that starts in primitive nerve cells. It rarely occurs after age around 10 years. Neuroblastoma is sometimes caused by a gene mutation passed from the parent to the child.
The report details the trend, potential and market size of Neuroblastoma Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neuroblastoma Treatmentmarket, defines the market attractiveness level of Neuroblastoma Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neuroblastoma Treatment industry, describes the types of Neuroblastoma Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neuroblastoma Treatment market and the development prospects and opportunities of Neuroblastoma Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neuroblastoma Treatment market in Chapter 13.
By Player:
NANT
Seattle Children’s
Texas Children’s
CureSearch
By Type:
Combination Chemotherapy
Monoclonal Antibody Therapy
Vaccine Therapy
Others
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neuroblastoma Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neuroblastoma Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neuroblastoma Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neuroblastoma Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neuroblastoma Treatment Market Analysis and Outlook to 2022
-
7.1 Global Neuroblastoma Treatment Consumption (2017-2022)
-
7.2 United States Neuroblastoma Treatment Consumption (2017-2022)
-
7.3 Europe Neuroblastoma Treatment Consumption (2017-2022)
-
7.4 China Neuroblastoma Treatment Consumption (2017-2022)
-
7.5 Japan Neuroblastoma Treatment Consumption (2017-2022)
-
7.6 India Neuroblastoma Treatment Consumption (2017-2022)
-
7.7 South Korea Neuroblastoma Treatment Consumption (2017-2022)
8 Region and Country-wise Neuroblastoma Treatment Market Analysis and Outlook to 2028
-
8.1 Global Neuroblastoma Treatment Consumption Forecast (2022-2028)
-
8.2 United States Neuroblastoma Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Neuroblastoma Treatment Consumption Forecast (2022-2028)
-
8.4 China Neuroblastoma Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Neuroblastoma Treatment Consumption Forecast (2022-2028)
-
8.6 India Neuroblastoma Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Neuroblastoma Treatment Consumption Forecast (2022-2028)
9 Global Neuroblastoma Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Neuroblastoma Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Combination Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Monoclonal Antibody Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Vaccine Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Neuroblastoma Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Neuroblastoma Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Neuroblastoma Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Combination Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Monoclonal Antibody Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Vaccine Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neuroblastoma Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Neuroblastoma Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neuroblastoma Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neuroblastoma Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neuroblastoma Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neuroblastoma Treatment Market Competitive Analysis
-
14.1 NANT
-
14.1.1 NANT Company Details
-
14.1.2 NANT Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 NANT Neuroblastoma Treatment Product and Service
-
14.2 Seattle Children’s
-
14.2.1 Seattle Children’s Company Details
-
14.2.2 Seattle Children’s Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Seattle Children’s Neuroblastoma Treatment Product and Service
-
14.3 Texas Children’s
-
14.3.1 Texas Children’s Company Details
-
14.3.2 Texas Children’s Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Texas Children’s Neuroblastoma Treatment Product and Service
-
14.4 CureSearch
-
14.4.1 CureSearch Company Details
-
14.4.2 CureSearch Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 CureSearch Neuroblastoma Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neuroblastoma Treatment
-
Figure Neuroblastoma Treatment Picture
-
Table Global Neuroblastoma Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuroblastoma Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuroblastoma Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neuroblastoma Treatment Consumption by Country (2017-2022)
-
Figure United States Neuroblastoma Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Neuroblastoma Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Neuroblastoma Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Neuroblastoma Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Neuroblastoma Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neuroblastoma Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Neuroblastoma Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Neuroblastoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neuroblastoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neuroblastoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neuroblastoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neuroblastoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neuroblastoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Combination Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibody Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccine Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Combination Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibody Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccine Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neuroblastoma Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neuroblastoma Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table NANT (Foundation Year, Company Profile and etc.)
-
Table NANT Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table NANT Neuroblastoma Treatment Product and Service
-
Table Seattle Children’s (Foundation Year, Company Profile and etc.)
-
Table Seattle Children’s Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Children’s Neuroblastoma Treatment Product and Service
-
Table Texas Children’s (Foundation Year, Company Profile and etc.)
-
Table Texas Children’s Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Texas Children’s Neuroblastoma Treatment Product and Service
-
Table CureSearch (Foundation Year, Company Profile and etc.)
-
Table CureSearch Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table CureSearch Neuroblastoma Treatment Product and Service
-
